Two Sigma Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $314K | Sell |
|
|||||
|
2023
Q4 | $386K | Sell |
|
|||||
|
2023
Q3 | $395K | Sell |
|
|||||
|
2023
Q2 | $548K | Sell |
|
|||||
|
2023
Q1 | $618K | Sell |
|
|||||
|
2022
Q4 | $768K | Buy |
|
|||||
|
2022
Q3 | $224K | Sell |
|
|||||
|
2022
Q2 | $241K | Buy |
|
|||||
|
2022
Q1 | $247K | Buy |
|
|||||
|
2021
Q4 | $293K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.49M | Sell |
|
|||||
|
2020
Q4 | $5.79M | Sell |
|
|||||
|
2020
Q3 | $16.4M | Sell |
|
|||||
|
2020
Q2 | $21.8M | Buy |
|
|||||
|
2020
Q1 | $14M | Sell |
|
|||||
|
2019
Q4 | $26.2M | Sell |
|
|||||
|
2019
Q3 | $26.4M | Sell |
|
|||||
|
2019
Q2 | $36.4M | Sell |
|
|||||
|
2019
Q1 | $41.3M | Buy |
|
|||||
|
2018
Q4 | $23.6M | Buy |
|
|||||
|
2018
Q3 | $42M | Sell |
|
|||||
|
2018
Q2 | $38.9M | Buy |
|
|||||
|
2018
Q1 | $25.1M | Buy |
|
|||||
|
2017
Q4 | $1.87M | Buy |
|
|||||
|
2017
Q3 | $638K | Buy |
|
|||||
|
2017
Q2 | $205K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $238K | Sell |
|
|||||
|
2015
Q3 | $248K | Buy |
|
|||||
|
2015
Q2 | $282K | Sell |
|
|||||
|
2015
Q1 | $2.2M | Buy |
|
|||||
|
2014
Q4 | $1.45M | Buy |
|
|||||
|
2014
Q3 | $1.02M | Buy |
|
|||||
|
2014
Q2 | $1.04M | Buy |
|
|||||
|
2014
Q1 | $377K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $352K | Buy |
|